Farm A (n = 140) | Farm B (n = 96) | Farm C (n = 104) | Total (n = 340) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
27–34 weeks (n = 63) | 45–60 weeks (n = 77) | Total | 27–34 weeks (n = 43) | 45–60 weeks (n = 53) | Total | 27–34 weeks (n = 46) | 45–60 weeks (n = 58) | Total | 27–34 weeks (n = 152) | 45–60 weeks (n = 188) | Total | |
General | ||||||||||||
Euthanised | 34 (54%) | 52 (67.5%) | 86 (61.4%) | 23 (53.5%) | 21 (39.6%) | 44 (45.8%) | 10 (21.7%) | 21 (36.2%) | 31 (29.8%) | 67 (44.1%) | 94 (50%) | 161 (47.4%) |
BW (kg) | 3.3 ± 0.5 | 3.3 ± 0.8 | 3.3 ± 0.6 | 3.0 ± 0.6 | 3.2 ± 0.8 | 3.1 ± 0.7 | 2.8 ± 0.6 | 3.4 ± 0.8 | 3.1 ± 0.8 | 3.1 ± 0.6 | 3.3 ± 0.8 | 3.2 ± 0.7 |
No. of males | 0 (0%) | 4 (5.2%) | 4 (2.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (6.5%) | 3 (5.2%) | 6 (5.8%) | 3 (2%) | 7 (3.7%) | 10 (2.9%) |
Dehydration | 19 (30.2%) | 24 (31.2%) | 43 (30.7%) | 9 (20.9%) | 27 (50.9%) | 36 (37.5%) | 15 (32.6%) | 25 (43.1%) | 40 (35.5%) | 43 (28.3%) | 76 (40.4%) | 119 (35%) |
Emaciation | 2 (3.2%) | 3 (3.9%) | 5 (3.6%) | 2 (4.7%) | 5 (9.4%) | 7 (7.3%) | 7 (15.2%) | 2 (3.4%) | 9 (8.7%) | 11 (7.2%) | 10 (5.3%) | 21 (6.2%) |
Skin, subcutis and foot pads | ||||||||||||
Laceration (mating injuries)a | 17 (27%) | 19 (25.7%) | 36 (25.7%) | 10 (23.3%) | 3 (5.7%) | 13 (13.5%) | 2 (4.3%) | 2 (3.4%) | 4 (3.8%) | 29 (19.1%) | 24 (12.8%) | 53 (15.6%) |
Bumblefootb | 1 (1.6%) | 3 (3.9%) | 4 (2.9%) | 0 (0%) | 2 (3.8%) | 2 (2.1%) | 1 (2.2%) | 0 (0%) | 1 (1%) | 2 (1.3%) | 5 (2.7%) | 7 (2.1%) |
Pododermatitisc | 40 (63.5%) | 23 (29.9%) | 63 (45%) | 13 (30.2%) | 17 (32.1%) | 30 (31.3%) | 22 (47.8%) | 36 (62.1%) | 58 (55.8%) | 75 (49.3%) | 76 (40.4%) | 151 (44.4%) |
Bursitis presternalis | 8 (12.7%) | 8 (10.4%) | 16 (11.4%) | 15 (34.9%) | 14 (26.4%) | 29 (30.2%) | 6 (13%) | 14 (24.1%) | 20 (19.2%) | 29 (19.1%) | 36 (19.1%) | 65 (19.1%) |
Skeletal system and joints | ||||||||||||
Fracture (long bones) | 1 (1.6%) | 4 (5.2%) | 5 (3.1%) | 0 (0%) | 4 (7.5%) | 4 (4.2%) | 0 (0%) | 2 (3.4%) | 2 (1.9%) | 1 (0.7%) | 10 (5.3%) | 11 (3.2%) |
Arthritisd | 2 (3.2%) | 6 (7.8%) | 8 (5.7%) | 3 (7%) | 7 (13.2%) | 10 (10.4%) | 8 (17.4%) | 2 (3.4%) | 10 (9.6%) | 13 (8.5%) | 15 (8%) | 28 (8.2%) |
Sternal fracture(s) | ||||||||||||
Total | 2 (3.2%) | 25 (32.5%) | 27 (19.3%) | 4 (9.3%) | 31 (58.5%) | 35 (36.5%) | 2 (4.3%) | 29 (50%) | 31 (29.8%) | 8 (5.3%) | 85 (45.2%) | 93 (27.4%) |
0 | 61 (96.8%) | 52 (67.5%) | 113 (80.7%) | 38 (88.4%) | 22 (41.5%) | 60 (62.5%) | 45 (97.8%) | 28 (48.3%) | 73 (70.2%) | 144 (94.7%) | 102 (54.3%) | 246 (72.4%) |
1 | 2 (3.8%) | 15 (19.5%) | 17 (12.1%) | 4 (9.3%) | 19 (35.8%) | 23 (24%) | 2 (4.3%) | 18 (31%) | 20 (19.2%) | 8 (5.3%) | 52 (27.7%) | 60 (17.6%) |
2 | 0 (0%) | 6 (7.8%) | 6 (4.3%) | 0 (0%) | 4 (7.5%) | 4 (4.2%) | 0 (0%) | 7 (12.1%) | 7 (6.7%) | 0 (0%) | 17 (9%) | 17 (5%) |
3 | 0 (0%) | 3 (3.9%) | 3 (2.1%) | 0 (0%) | 6 (11.3%) | 6 (6.3%) | 0 (0%) | 3 (5.2%) | 3 (2.9%) | 0 (0%) | 12 (6.4%) | 12 (3.5%) |
> 4 | 0 (0%) | 1 (1.3%) | 1 (0.7%) | 0 (0%) | 2 (3.8%) | 2 (2.1%) | 0 (0%) | 1 (1.7%) | 1 (1%) | 0 (0%) | 4 (2.1%) | 4 (1.2%) |
Respiratory system | ||||||||||||
Tracheal changese | 21 (33.3%) | 18 (23.4%) | 39 (27.9%) | 11 (25.6%) | 9 (17%) | 20 (20.8%) | 22 (47.9%) | 23 (39.7%) | 45 (43.3%) | 54 (35.5%) | 50 (26.6%) | 104 (30.6%) |
Pulmonary changesf | 25 (39.7%) | 27 (35.1%) | 52 (37.1%) | 16 (37.2%) | 18 (34%) | 34 (35.4%) | 21 (45.7%) | 22 (37.9%) | 43 (41.3%) | 62 (40.8%) | 67 (35.6%) | 129 (38%) |
Airsacculitisg | 14 (22.2%) | 14 (18.2%) | 28 (20%) | 6 (14%) | 4 (7.5%) | 10 (10.4%) | 12 (26.1%) | 13 (22.4%) | 25 (24%) | 32 (21.1%) | 31 (16.5%) | 63 (18.5%) |
Coelomic cavity | ||||||||||||
Pericarditish | 6 (9.5%) | 3 (3.9%) | 9 (6.4%) | 1 (2.3%) | 2 (3.8%) | 3 (3.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (4.6%) | 5 (2.7%) | 12 (3.5%) |
Perihepatitish | 6 (9.5%) | 3 (3.9%) | 9 (6.4%) | 3 (7%) | 1 (1.9%) | 4 (4.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 9 (5.9%) | 4 (2.1%) | 13 (3.8%) |
Fatty liver | 15 (23.8%) | 9 (11.7%) | 24 (17.1%) | 5 (11.6%) | 5 (9.4%) | 10 (10.4%) | 0 (0%) | 5 (8.6%) | 5 (4.8%) | 20 (13.2%) | 19 (10.1%) | 39 (11.5%) |
Hepatic rupture | 2 (3.2%) | 2 (2.6%) | 4 (2.9%) | 0 (0%) | 3 (5.7%) | 3 (3.1%) | 1 (2.2%) | 5 (8.6%) | 6 (5.8%) | 3 (2%) | 10 (5.3%) | 13 (3.8%) |
Peritonitish | 23 (36.5%) | 28 (36.4%) | 51 (36.4%) | 10 (23.3%) | 15 (28.3%) | 25 (26%) | 11 (23.9%) | 19 (32.8%) | 30 (28.8%) | 44 (28.4%) | 62 (33%) | 106 (31.2%) |
Renal changesi | 17 (27%) | 24 (31.2%) | 41 (29.3%) | 11 (25.6%) | 19 (35.8%) | 30 (31.3%) | 27 (58.7%) | 23 (39.7%) | 50 (48.1%) | 55 (36.2%) | 66 (35.1%) | 121 (35.6%) |
Reproductive system | ||||||||||||
In layj | 39 (61.9%) | 20 (27.4%) | 59 (43.4%) | 16 (37.2%) | 21 (39.6%) | 37 (38.5%) | 12 (27.9%) | 27 (49.1%) | 39 (39.8%) | 67 (44.1%) | 68 (36.2%) | 135 (40.9%) |
Egg bound | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.8%) | 2 (2.1%) | 3 (7%) | 1 (1.8%) | 4 (4.1%) | 3 (2%) | 3 (1.6%) | 6 (1.8%) |
Perioophoritish | 8 (12.7%) | 17 (23.3%) | 25 (18.4%) | 4 (9.3%) | 12 (22.6%) | 16 (16.7%) | 5 (11.6%) | 10 (18.2%) | 15 (15.3%) | 17 (11.9%) | 39 (20.7%) | 56 (17%) |
Ovarian regressionk | 14 (22.2%) | 28 (38.4%) | 42 (30.9%) | 15 (34.9%) | 21 (39.6%) | 36 (37.5%) | 20 (46.5%) | 28 (50.9%) | 48 (49%) | 49 (32.2%) | 77 (41%) | 126 (38.2%) |
Salpingitisl | 14 (22.2%) | 10 (13.7%) | 24 (17.6%) | 8 (18.6%) | 10 (18.9%) | 18 (18.8%) | 5 (11.6%) | 9 (16.4%) | 14 (14.3%) | 27 (17.8%) | 29 (15.4%) | 56 (17%) |
Regressed salpinxm | 6 (9.5%) | 16 (21.9%) | 22 (16.2%) | 7 (16.3%) | 18 (34%) | 25 (26%) | 15 (34.9%) | 20 (36.4%) | 35 (35.7%) | 28 (18.4%) | 54 (28.7%) | 82 (24.8%) |
Cystic right oviduct/reminiscence | 9 (14.3%) | 14 (19.2%) | 23 (16.9%) | 8 (18.6%) | 17 (32.1%) | 25 (26%) | 0 (0%) | 6 (10.9%) | 6 (6.1%) | 17 (11.2%) | 37 (19.7%) | 54 (16.4%) |
Miscellaneous | ||||||||||||
Cannibalism | 4 (6.3%) | 3 (3.9%) | 7 (5%) | 0 (0%) | 1 (1.9%) | 1 (1%) | 1 (2.2%) | 0 (0%) | 1 (1%) | 5 (3.3%) | 4 (2.1%) | 9 (2.6%) |
Neoplasia | 1 (1.6%) | 0 (0%) | 1 (0.7%) | 0 (0%) | 3 (5.7%) | 3 (3.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.7%) | 3 (1.6%) | 4 (1.2%) |